Appendix 1.  Summary of Sponsor’s Risk Communication Plan*

 

Activities Directed to Physicians

 

-         Dear Healthcare Professional Letters

-         Physician Speaker Training

-         Wellbutrin XL Dose Card to instruct physicians on proper dosing

-         Prescription Pad Ink Stamp which includes name and dosing instructions

-         Physician Website

 

 

Activities Directed to Pharmacists

 

-         Dear Healthcare Professional Letters

-         Pharmacy Shelf Sheet (with information on proper dosing)

-         One-page Educational Sheet from Sales Representatives

-         Communication in Pharmacy Journals

-         Trade Container Labeling and Carton

 

 

Activities Directed to Patients

 

-         Patient Education Available from Physician

-         Patient Package Insert

-         Tear-Off Pads of Patient Package Insert

-         Consumer Website

-         Sample Container Labeling

 

 

Other Activities

 

-         Sales Representative Training

-         Training for use by Sponsor’s Customer Response Center

-         Medication Error Reporting

 

 

 

STAMPED: APPEARS THIS WAY ON ORIGINAL

 

*Detailed information appears in the sponsor’s submission dated July 3, 2003.

 

 

6

 

 

Back a Page
Next Page
Back to Wellbutrin XL NDA Index Page
Back to Main Index Page